v3.26.1
Investments
3 Months Ended
Apr. 30, 2026
Investments, Debt and Equity Securities [Abstract]  
Investments Investments
Marketable Securities
As of April 30, 2026 and January 31, 2026, our marketable securities consisted of the following:
As of April 30, 2026
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair
Value
(in thousands)
U.S. government agency securities$5,598,728 $3,650 $(11,962)$5,590,416 
Agency bonds1,198,350 234 (3,431)1,195,153 
Treasury bills44,474 — (6)44,468 
Marketable securities$6,841,552 $3,884 $(15,399)$6,830,037 
As of January 31, 2026
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair
Value
(in thousands)
U.S. government agency securities$5,373,782 $11,094 $(989)$5,383,887 
Agency bonds1,095,004 1,032 (565)1,095,471 
Treasury bills64,671 (3)64,673 
Marketable securities$6,533,457 $12,131 $(1,557)$6,544,031 
Unrealized losses for securities that have been in an unrealized loss position for less than 12 months were $15.4 million and $1.5 million as of April 30, 2026 and January 31, 2026, respectively. Unrealized losses for securities that have been in an unrealized loss position for 12 months or longer were de minimis as of both April 30, 2026 and January 31, 2026. We review the individual securities that have unrealized losses on a regular basis to evaluate whether any security has experienced, or is expected to experience, credit losses resulting in the decline in fair value. We evaluate, among other factors, whether we have the intention to sell any of these marketable securities and whether it is more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. We have not recorded an allowance for credit losses, as we believe any such losses would be immaterial based on the high-grade credit rating for each of our marketable securities as of the end of each period. There were no material realized gains or losses from available-for-sale securities that were reclassified out of accumulated other comprehensive income for the three months ended April 30, 2026 and 2025.
The following table presents the contractual maturities of our marketable securities as of April 30, 2026 and January 31, 2026:
As of
April 30, 2026January 31, 2026
(in thousands)
Less than one year$3,118,570 $3,168,258 
Due in one to five years3,711,467 3,375,773 
Total$6,830,037 $6,544,031 
Strategic Investments
Strategic investments by type and measurement category as of April 30, 2026 were as follows:
Measurement Category
Fair ValueMeasurement AlternativeEquity MethodTotal
(in thousands)
Equity securities$— $1,748,737 $123,704 $1,872,441 
Debt securities3,978 — — 3,978 
Strategic investments$3,978 $1,748,737 $123,704 $1,876,419 
Strategic investments by type and measurement category as of January 31, 2026 were as follows:
Measurement Category
Fair ValueMeasurement AlternativeEquity MethodTotal
(in thousands)
Equity securities$— $1,448,531 $126,112 $1,574,643 
Debt securities3,968 — — 3,968 
Strategic investments$3,968 $1,448,531 $126,112 $1,578,611 
During the three months ended April 30, 2026, we made an additional $46.0 million investment in preferred stock of Anthropic, PBC (“Anthropic”), bringing the total carrying value of our Anthropic preferred stock to $1,266.9 million, based on the valuation implied by Anthropic’s financing round announced on February 12, 2026. Additionally, during the three months ended April 30, 2026, we made a total of $99.7 million of strategic investments in equity securities of other private companies developing AI products. Based on the terms of these investments in privately-held securities, we determined that we do not have a controlling interest or the ability to exercise significant influence over the operating and financial policies of the investees. Therefore, these investments are accounted for under the measurement alternative method.
During the three months ended April 30, 2026, we recorded net unrealized gains of $154.5 million on our investments accounted for under the measurement alternative method, which were attributable to investments other than our investment in Anthropic.